BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 28330604)

  • 1. Stable and Potent Selenomab-Drug Conjugates.
    Li X; Nelson CG; Nair RR; Hazlehurst L; Moroni T; Martinez-Acedo P; Nanna AR; Hymel D; Burke TR; Rader C
    Cell Chem Biol; 2017 Apr; 24(4):433-442.e6. PubMed ID: 28330604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utilization of Selenocysteine for Site-Specific Antibody Conjugation.
    Li X; Rader C
    Methods Mol Biol; 2017; 1575():145-164. PubMed ID: 28255878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Site-specific antibody-drug conjugation through an engineered glycotransferase and a chemically reactive sugar.
    Zhu Z; Ramakrishnan B; Li J; Wang Y; Feng Y; Prabakaran P; Colantonio S; Dyba MA; Qasba PK; Dimitrov DS
    MAbs; 2014; 6(5):1190-200. PubMed ID: 25517304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecularly defined antibody conjugation through a selenocysteine interface.
    Hofer T; Skeffington LR; Chapman CM; Rader C
    Biochemistry; 2009 Dec; 48(50):12047-57. PubMed ID: 19894757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Site-Specific Antibody Drug Conjugates Using Streamlined Expressed Protein Ligation.
    Frutos S; Hernández JL; Otero A; Calvis C; Adan J; Mitjans F; Vila-Perelló M
    Bioconjug Chem; 2018 Nov; 29(11):3503-3508. PubMed ID: 30346741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rational design, biophysical and biological characterization of site-specific antibody-tubulysin conjugates with improved stability, efficacy and pharmacokinetics.
    Thompson P; Fleming R; Bezabeh B; Huang F; Mao S; Chen C; Harper J; Zhong H; Gao X; Yu XQ; Hinrichs MJ; Reed M; Kamal A; Strout P; Cho S; Woods R; Hollingsworth RE; Dixit R; Wu H; Gao C; Dimasi N
    J Control Release; 2016 Aug; 236():100-16. PubMed ID: 27327768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sortase Enzyme-Mediated Generation of Site-Specifically Conjugated Antibody Drug Conjugates with High In Vitro and In Vivo Potency.
    Beerli RR; Hell T; Merkel AS; Grawunder U
    PLoS One; 2015; 10(7):e0131177. PubMed ID: 26132162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Efficient Conjugation Approach for Coupling Drugs to Native Antibodies via the Pt
    Merkul E; Muns JA; Sijbrandi NJ; Houthoff HJ; Nijmeijer B; van Rheenen G; Reedijk J; van Dongen GAMS
    Angew Chem Int Ed Engl; 2021 Feb; 60(6):3008-3015. PubMed ID: 33185916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Site-Specific Dual Antibody Conjugation via Engineered Cysteine and Selenocysteine Residues.
    Li X; Patterson JT; Sarkar M; Pedzisa L; Kodadek T; Roush WR; Rader C
    Bioconjug Chem; 2015 Nov; 26(11):2243-8. PubMed ID: 26161903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetically Encoded Azide Containing Amino Acid in Mammalian Cells Enables Site-Specific Antibody-Drug Conjugates Using Click Cycloaddition Chemistry.
    VanBrunt MP; Shanebeck K; Caldwell Z; Johnson J; Thompson P; Martin T; Dong H; Li G; Xu H; D'Hooge F; Masterson L; Bariola P; Tiberghien A; Ezeadi E; Williams DG; Hartley JA; Howard PW; Grabstein KH; Bowen MA; Marelli M
    Bioconjug Chem; 2015 Nov; 26(11):2249-60. PubMed ID: 26332743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human Serum Albumin Domain I Fusion Protein for Antibody Conjugation.
    Patterson JT; Wilson HD; Asano S; Nilchan N; Fuller RP; Roush WR; Rader C; Barbas CF
    Bioconjug Chem; 2016 Oct; 27(10):2271-2275. PubMed ID: 27666414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted drug delivery through the traceless release of tertiary and heteroaryl amines from antibody-drug conjugates.
    Staben LR; Koenig SG; Lehar SM; Vandlen R; Zhang D; Chuh J; Yu SF; Ng C; Guo J; Liu Y; Fourie-O'Donohue A; Go M; Linghu X; Segraves NL; Wang T; Chen J; Wei B; Phillips GD; Xu K; Kozak KR; Mariathasan S; Flygare JA; Pillow TH
    Nat Chem; 2016 Dec; 8(12):1112-1119. PubMed ID: 27874860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of site-specific antibody-drug conjugates using unnatural amino acids.
    Axup JY; Bajjuri KM; Ritland M; Hutchins BM; Kim CH; Kazane SA; Halder R; Forsyth JS; Santidrian AF; Stafin K; Lu Y; Tran H; Seller AJ; Biroc SL; Szydlik A; Pinkstaff JK; Tian F; Sinha SC; Felding-Habermann B; Smider VV; Schultz PG
    Proc Natl Acad Sci U S A; 2012 Oct; 109(40):16101-6. PubMed ID: 22988081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Site-Specific Antibody-Drug Conjugates in Triple Variable Domain Fab Format.
    Hwang D; Rader C
    Biomolecules; 2020 May; 10(5):. PubMed ID: 32422893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Harnessing a catalytic lysine residue for the one-step preparation of homogeneous antibody-drug conjugates.
    Nanna AR; Li X; Walseng E; Pedzisa L; Goydel RS; Hymel D; Burke TR; Roush WR; Rader C
    Nat Commun; 2017 Oct; 8(1):1112. PubMed ID: 29062027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A general approach to site-specific antibody drug conjugates.
    Tian F; Lu Y; Manibusan A; Sellers A; Tran H; Sun Y; Phuong T; Barnett R; Hehli B; Song F; DeGuzman MJ; Ensari S; Pinkstaff JK; Sullivan LM; Biroc SL; Cho H; Schultz PG; DiJoseph J; Dougher M; Ma D; Dushin R; Leal M; Tchistiakova L; Feyfant E; Gerber HP; Sapra P
    Proc Natl Acad Sci U S A; 2014 Feb; 111(5):1766-71. PubMed ID: 24443552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Taxane-antibody conjugates afford potent cytotoxicity, enhanced solubility, and tumor target selectivity.
    Guillemard V; Saragovi HU
    Cancer Res; 2001 Jan; 61(2):694-9. PubMed ID: 11212270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. chFRP5-ZZ-PE38, a large IgG-toxin immunoconjugate outperforms the corresponding smaller FRP5(Fv)-ETA immunotoxin in eradicating ErbB2-expressing tumor xenografts.
    Mazor Y; Noy R; Wels WS; Benhar I
    Cancer Lett; 2007 Nov; 257(1):124-35. PubMed ID: 17698286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioprocess development of antibody-drug conjugate production for cancer treatment.
    Ou J; Si Y; Goh K; Yasui N; Guo Y; Song J; Wang L; Jaskula-Sztul R; Fan J; Zhou L; Liu R; Liu X
    PLoS One; 2018; 13(10):e0206246. PubMed ID: 30352095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of attachment site on stability of cleavable antibody drug conjugates.
    Dorywalska M; Strop P; Melton-Witt JA; Hasa-Moreno A; Farias SE; Galindo Casas M; Delaria K; Lui V; Poulsen K; Loo C; Krimm S; Bolton G; Moine L; Dushin R; Tran TT; Liu SH; Rickert M; Foletti D; Shelton DL; Pons J; Rajpal A
    Bioconjug Chem; 2015 Apr; 26(4):650-9. PubMed ID: 25643134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.